23 results
6-K
EX-99.2
PHVS
Pharvaris NV
10 Apr 24
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:11pm
.”
Mr. Nassif continued, “The progress Pharvaris has made to date demonstrates the strength of the leadership, the expertise of the talent throughout … talent in the industry with deep expertise in rare diseases and HAE. For more information, visit https://pharvaris.com/.
Forward-Looking Statements
6-K
EX-99.1
PHVS
Pharvaris NV
10 Apr 24
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:11pm
. The company brings together the best talent in the industry with deep expertise in rare diseases and HAE. For more information, visit https
6-K
EX-99.1
PHVS
Pharvaris NV
16 Feb 24
Pharvaris Announces Extraordinary Meeting of Shareholders
6:51am
and prophylactically. The company brings together the best talent in the industry with deep expertise in rare diseases and HAE. For more information, visit
6-K
EX-99.1
PHVS
Pharvaris NV
22 Jan 24
Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks
6:51am
and prophylactically. The company brings together the best talent in the industry with deep expertise in rare diseases and HAE. For more information, visit https
FWP
ail71j aead
6 Dec 23
Free writing prospectus
7:08am
6-K
EX-99.3
squepmr8wwf1q 5cg
6 Dec 23
Current report (foreign)
6:52am
6-K
EX-99.1
skis29j
2 Nov 23
Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update
6:51am
6-K
EX-99.1
e96s2z27b5 td0
7 Aug 23
Pharvaris Reports Second Quarter 2023 Financial Results and Provides Business Update
6:51am
6-K
EX-99.1
d0io7m22 gwovzt7gooi
26 Jun 23
Pharvaris Announces FDA Removal of Clinical Hold of Deucrictibant for the On-Demand Treatment of HAE
6:50am
6-K
EX-99.2
m0fd1x8gxlmqjl1fz43
20 Jun 23
Current report (foreign)
6:50am
6-K
EX-99.1
pdrsx 0512k
1 Jun 23
Pharvaris Announces Annual Meeting of Shareholders
6:51am
6-K
EX-99.1
gr7cgz9ctwep 4hv08w
8 May 23
Pharvaris Reports First Quarter 2023 Financial Results and Provides Business Update
6:51am
6-K
EX-99.1
54urzsv3 xh4gamjk
5 Apr 23
Pharvaris Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
6:53am
6-K
EX-99.2
y6o6vsbn6qscss5
8 Dec 22
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
6:51am
6-K
EX-99.1
uj98mh nuaejs0g
8 Dec 22
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
6:51am
6-K
EX-99.1
ac0em
12 Sep 22
Pharvaris Reports Second Quarter 2022 Financial Results and Provides Business Update
6:51am
6-K
EX-99.1
6fp53
22 Aug 22
6-K - Press Release 22.08.2022
6:50am
6-K
EX-99.1
oiqh1cn64eai9c3
14 Jun 22
Pharvaris Announces Annual Meeting of Shareholders
8:00am